Skip to main content
CLOV logo

CLOV · Clover Health Investments, Corp. · Executive Compensation

Track CLOV — free
$3.77 -0.40 (-9.59%) At close · Nov 19 Play latest call Q2 2026 earnings call transcript
Market Cap
$2.02B
Shares
535.42M
Volume · Nov 19 8.34M Avg daily vol (3M) 4.42M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Peter Kuipers $2,045,067
Jamie L. Reynoso $1,468,166
Andrew Toy $1,319,385
Conrad Wai $1,211,938
Brady Priest $1,199,461
Fiscal 2024
Executive Total
Andrew Toy $9,476,723
Peter Kuipers $4,984,336
Jamie L. Reynoso $4,792,147
Conrad Wai $4,465,698
Brady Priest $4,454,821
Terry Ronan $1,008,897
Scott J. Leffler $36,986
Fiscal 2023
Executive Total
Andrew Toy $10,154,701
Jamie L. Reynoso $2,494,844
Karen Soares $1,466,496
Scott J. Leffler $1,402,851
Brady Priest $1,346,996
Fiscal 2022
Executive Total
Scott J. Leffler $13,529,434
Andrew Toy $10,171,476
Joseph Martin $8,903,471
Brady Priest $4,534,758
Jamie L. Reynoso $2,929,875
Mark Herbers $1,249,500
Vivek Garipalli —
Fiscal 2021
Executive Total
Vivek Garipalli $389,569,439
Andrew Toy $141,987,507
Jamie L. Reynoso $3,048,484
Prabhdeep Singh $2,679,325
Mark Herbers $1,034,886
Joseph Wagner $407,342
Fiscal 2020
Executive Total
Andrew Toy $8,617,885
Vivek Garipalli —
Fiscal 2019
Executive Total
Andrew Toy $423,593
Vivek Garipalli —

Executive changes

Person Change Filed
Joseph Frank Oldakowski Appointed 2026-11-04
Joseph Clay Thornton Appointed 2026-11-04
Brian J. Miller Appointed 2026-09-24
Robert G. Torricelli Appointed 2026-09-24
Brady Priest
“Mr. Priest’s departure was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2026-06-16
Joseph (Joe) Oldakowski Appointed 2026-04-01
Clay Thornton Appointed 2026-04-01
Chelsea Clinton
“Ms. Clinton’s decision to step down from the Board is not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2025-10-31
Thomas L. Tran Appointed 2025-04-22
Thomas L. Tran Appointed 2024-08-22
Peter Kuipers Appointed 2024-04-22
Terrence Ronan Appointed 2023-12-27
Terrence Ronan Appointed 2023-12-27
Scott J. Leffler
“Mr. Leffler noted to the Company that his departure does not reflect any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2023-12-21
Joseph Martin Resigned 2023-06-08
Prabhdeep Singh Resigned 2023-01-20
Jamie L. Reynoso Appointed 2023-01-10
Anna Loengard, M.D. Appointed 2022-11-30
Andrew Toy Appointed 2022-08-10
Vivek Garipalli Appointed 2022-08-10
Carladenise Armbrister Edwards, Ph.D. Appointed 2022-07-26
Nathaniel S. Turner
“Mr. Turner’s resignation as a director was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.”
Resigned 2022-05-27
Karen Soares Appointed 2022-01-19
Gia Lee
“Ms. Lee noted to the Company that her departure is not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.”
Resigned 2022-01-19
Mark Herbers Appointed 2021-08-16

Leadership

Key facts CIK 1801170 CUSIP 18914F103 13F (30d) 233 filings 213 filers Visit website Investor relations